Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vaginal epithelial cell surface glycans are complex carbohydrate structures, including N-linked and O-linked glycans, that form a dense layer known as the glycocalyx on the vaginal mucosa (Moncla et al., 2015, Journal of Medical Microbiology). These glycans serve as critical mediators of the vaginal microenvironment, acting as attachment sites for beneficial commensal bacteria like Lactobacillus, which are essential for maintaining vaginal health (García-Kassbi et al., 2022, Frontiers in Cellular and Infection Microbiology). However, these same glycans are often exploited by pathogens, such as HIV-1, Herpes Simplex Virus (HSV), and Candida albicans, as receptors or co-receptors to facilitate adhesion and subsequent infection (Nunn et al., 2015, Biology of Reproduction). The composition of these glycans can be influenced by hormonal changes during the menstrual cycle, which in turn affects the susceptibility of the vaginal epithelium to various infections (O'Hanlon et al., 2013, PLOS ONE). Therapeutic strategies targeting these glycans include the development of microbicides and lectins, such as Griffithsin, which bind to specific glycan motifs to block pathogen entry (O'Keefe et al., 2009, PNAS). Additionally, understanding the glycan profile of the vaginal epithelium is vital for the design of targeted probiotic therapies aimed at restoring a healthy microbiome. These interventions often focus on competitive inhibition, where therapeutic agents occupy glycan docking sites to prevent pathogen colonization or enhance the host's natural mucosal defenses.
Competitive inhibition of pathogen binding to host cell surface glycans; enhancement of the mucosal barrier through glycan-mimetic polymers; promotion of commensal bacterial adhesion to stabilize the vaginal microbiome.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vaginal epithelial cell surface glycans.